Hypoxia-inducible Factor-1alpha: Molecular-targeted Therapy for Hepatocellular Carcinoma

E-ISSN： 1875-5607|13|9|1295-1304

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.13, Iss.9, 2013-07, pp. : 1295-1304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting hypoxia-inducible factor-1 for therapy and prevention

By Zhong Hua

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. : 951-966

Informa Healthcare

Access to resources Recommend Favorite

Cancer Therapy By Targeting Hypoxia-Inducible Factor-1

Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. : 782-796

Bentham Science Publishers

Access to resources Recommend Favorite

Down-regulating Glypican-3 Expression: Molecular-targeted Therapy for Hepatocellular Carcinoma

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 14, 2014-12 ,pp. : 1183-1193

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma

Current Cancer Drug Targets, Vol. 16, Iss. 1, 2016-01 ,pp. : 53-70

Bentham Science Publishers

Access to resources Recommend Favorite

Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel–Lindau-dependent pathway

By Li Ching-Hao Liao Po-Lin Yang Ya-Ting Huang Shih-Hsuan Lin Cheng-Hui Cheng Yu-Wen Kang Jaw-Jou

Archives of Toxicology, Vol. 88, Iss. 3, 2014-03 ,pp. : 659-671

Springer Publishing Company

Access to resources Recommend Favorite